Personalis (PSNL) Liabilities and Shareholders Equity (2018 - 2026)
Personalis (PSNL) recorded quarterly Liabilities and Shareholders Equity of $325.4 million in Q1 2026, down 2.62% quarter-over-quarter from $334.2 million in Q4 2025, and up 19.06% on a YoY basis from $273.3 million in Q1 2025.
Personalis (PSNL) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends
Personalis' Liabilities and Shareholders Equity history runs 9 years deep, the most recent figure standing at $325.4 million for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 19.06% year-over-year to $325.4 million; the TTM figure through Mar 2026 stood at $1.2 billion (up 19.83% YoY), while the FY2025 annual figure was $334.2 million, up 23.64% from the prior year.
- Liabilities and Shareholders Equity was $325.4 million for Q1 2026 at Personalis, down from $334.2 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $380.6 million in Q1 2022 to a low of $185.5 million in Q2 2024.
- Historically, Liabilities and Shareholders Equity has averaged $273.4 million across 5 years, with a median of $270.3 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity sank 30.43% in 2023, then soared 39.96% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $292.7 million in 2022, then retreated by 23.1% to $225.1 million in 2023, then climbed by 20.07% to $270.3 million in 2024, then advanced by 23.64% to $334.2 million in 2025, then retreated by 2.62% to $325.4 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $325.4 million (Q1 2026), $334.2 million (Q4 2025), and $242.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 24.53 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 113.28 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 83.54 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 3.39 Bn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 13.07 Bn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 2.61 Bn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 29.68 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 6.56 Bn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 3.67 Bn |
| 10 | Personalis | 1.01 Bn | 780.57 Mn | 281,000.00 | 325.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 325.40 Mn |
| Dec 31, 2025 | 334.16 Mn |
| Sep 30, 2025 | 242.84 Mn |
| Jun 30, 2025 | 258.68 Mn |
| Mar 31, 2025 | 273.31 Mn |
| Dec 31, 2024 | 270.27 Mn |
| Sep 30, 2024 | 239.89 Mn |
| Jun 30, 2024 | 185.50 Mn |
| Mar 31, 2024 | 195.28 Mn |
| Dec 31, 2023 | 225.10 Mn |
| Sep 30, 2023 | 226.64 Mn |
| Jun 30, 2023 | 249.04 Mn |
| Mar 31, 2023 | 272.18 Mn |
| Dec 31, 2022 | 292.70 Mn |
| Sep 30, 2022 | 317.86 Mn |
| Jun 30, 2022 | 357.98 Mn |
| Mar 31, 2022 | 380.65 Mn |
| Dec 31, 2021 | 396.53 Mn |
| Sep 30, 2021 | 406.69 Mn |
| Jun 30, 2021 | 383.34 Mn |